Relieved Glucose Variability in Patient with Type 2 Diabetes (T2D) And Cerebral Vascular Accident (CVA) Treated by Zultophy and Equmet (Vildagliptin/Metformin)

Bando H, Ogawa T, Iwatsuki N, Okada M and Sakamoto K

Published on: 2023-09-01


This case is a 64-year-old male patient with cerebral vascular accident (CVA), hypertension and T2D. He developed diplopia, blurred vision and vertigo in January 2020, and was diagnosed as left abducens nerve palsy with CVA. Brain MRI in DW1 showed high intensity from the dorsal side of the tegmentum to the right side of the medulla oblongata of Pons. He was provided Xultophy accompanied with some efficacy. HbA1c increased to 8.8% in March 2023, and then intake of Twymeeg showed effect as 6.7% in June. The cardio-ankle vascular index (CAVI) showed elevation from 8.5 to 14.2 for 5 years.